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Abstract The interaction of the inhibitor 2,5-dibromo-3-
methyl-6-isopropylbenzoquinone (DBMIB) with the Rieske
protein of the chloroplast b6f complex has been studied by
EPR. All three redox states of DBMIB were found to interact
with the iron-sulphur cluster. The presence of the oxidised form
of DBMIB altered the equilibrium distribution of the Rieske
protein’s conformational substates, strongly favouring the
proximal position close to heme bL. In addition to this
conformational effect, DBMIB shifted the pK-value of the
redox-linked proton involved in the iron-sulphur cluster’s redox
transition by about 1.5 pH units towards more acidic values. The
implications of these results with respect to the interaction of the
native quinone substrate and the Rieske cluster in cytochrome bc
complexes are discussed.
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1. Introduction
Dramatic progress in our understanding of cytochrome bc
complexes has recently been achieved by the determination of
the 3D-structure of the mitochondrial cytochrome bc1 com-
plex [1^3]. In addition to a detailed structural description of
the enzyme, the X-ray work provided evidence for a long-
range domain movement of the Rieske protein within the
complex. This domain movement obviously allows the [2Fe-
2S]-cluster of the Rieske protein to shuttle an electron from its
substrate quinol towards cyt c1 representing a novel mecha-
nism for intra-complex electron transfer. EPR experiments on
partially ordered samples have demonstrated that the confor-
mational £exibility of the Rieske protein in cytochrome bc
complexes is not unique to the mitochondrial enzyme [4^6].
Stimulated by the 3D-structures, detailed mechanistic mod-
els for quinol oxidation by cytochrome bc complexes [7^9] and
more speci¢cally for the role of the moving Rieske protein
during turnover were proposed recently [10]. A crucial param-
eter in the model of Ugulava and Crofts [10] is the pK-value
of the NO-proton on one of the cluster-ligating histidines. This
pK-value indeed appears to be surprisingly well-conserved (at
a value of close to pH 8) in all Rieske proteins from neutro-
philic organisms [10,11]. Only the Rieske proteins from acid-
ophilic organisms show signi¢cantly altered pK-values of the
redox-linked protons [6,12].
Based on the sensitivity of the Rieske centre’s EPR spec-
trum towards the redox state of the quinone occupying the
Qo-site, strong hydrogen interactions between the hydroxyl/
phenoxy-functions on the quinol/ne and the NO-protons on
the histidine ligand have been proposed several years ago
[13]. These hypotheses are comforted by the positions of
Qo-site inhibitors as seen in the 3D-structures [2,3]. The struc-
tural model proposed by Ding et al. [13] suggests a possible
in£uence of the protonation/redox state of the quinone on the
pK-value of the proton on the histidine ligand. Such modi¢-
cations of the pK-value on the histidine ligands depending on
the redox state of the quinone may well be of functional sig-
ni¢cance but are di⁄cult to study experimentally for the case
of the physiological quinone substrate.
In this work, we show that the Rieske protein in cyto-
chrome b6f complex from spinach also displays conformation-
al £exibility. Occupancy of the Qo-site by the inhibitor
DBMIB locks the majority of Rieske proteins in the proximal
position (i.e. close to heme bL) and leads to a substantial pK-
shift of the redox-linked proton suggesting the possibility of
comparable e¡ects induced by the native quinone.
2. Materials and methods
Broken thylakoids were prepared from market spinach and cyto-
chrome b6f complex was puri¢ed according to [14].
EPR redox titrations were performed as described by Dutton [15]
using the following redox mediators at 100 WM: N,N-dimethyl-p-
phenylenediamine, 1,4-benzoquinone, N,N,N’,N’-tetramethyl-p-phen-
ylenediamine, diaminodurol, 2,6-dichlorophenolindophenol, 1,2-naph-
thoquinone, toluylene blue, phenazine methosulphate, phenazine
ethosulphate, methylene blue, duroquinone. Fifty mM MES, MOPS
and HEPES were present during titrations at pH 5.7, 6.3, 6.9, 7.1 and
8.0. Reductive and oxidative titrations were performed using dithio-
nite and potassium ferricyanide, respectively.
EPR spectra were recorded on a Bruker ESP300e X-band spectrom-
eter ¢tted with an Oxford Instrument He-cryostat and temperature
control system.
Partially ordered samples were obtained from puri¢ed cytochrome
b6f complex as reported previously [16^18].
DBMIB and analogs were kindly provided by Prof. Walter Oett-
meier Bochum, Germany.
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The inhibitors were reduced in ethyleneglycol by addition of sodium
borohydride followed by chemical decomposition of the reductant via
acidi¢cation.
The structure depicted in Fig. 5 is partly based on the X-ray struc-
ture of the mitochondrial cytochrome bc1 complex [2] (pdb-entry
3bcc).
3. Results and discussion
Halogenated quinone analogs and in particular the dibro-
mo-derivative DBMIB [19^21] have been described as potent
inhibitors of the chloroplast cytochrome b6f complex [22^26]
and with much lesser e⁄ciency of cytochrome bc1 complexes
from mitochondria [27] and purple bacteria [28]. DBMIB was
shown to bind at the Qo-site of the enzyme and to strongly
alter the EPR spectrum of the Rieske cluster (in particular,
inducing a shift of the gy-line from 1.89 to 1.94) [24].
Based on an EPR redox titration at pH 8.0 of DBMIB-
treated thylakoids, the existence of four paramagnetically dif-
fering states of the complex between DBMIB and the b6f
Rieske protein had been proposed (see Scheme 1) [23]. Ac-
cording to this model, the inhibitor-induced spectral altera-
tions (i.e. appearance of the g = 1.94 signal) are only observed
in the presence of the oxidised form of DBMIB (state 2),
whereas the singly reduced semiquinone was proposed to cou-
ple antiferromagnetically to the paramagnetic centre of the
Rieske cluster yielding the EPR-silent state 3 [23]. In the fully
reduced state 4 of the inhibitor (DBMIBH2), the gy = 1.89 line
was observed to reappear suggesting that either DBMIBH2
does not bind to the enzyme or that the binding is modi¢ed
in a way abolishing the characteristic strong interaction be-
tween the inhibitor and the Rieske centre [23].
Fig. 1a shows EPR spectra obtained on puri¢ed cyto-
chrome b6f complex reduced by ascorbate in the presence
(continuous line) and absence (dotted line) of DBMIBH2.
Whereas a g = 1.94 signal was present at very minor amounts
(most probably due to incomplete chemical prereduction of
the inhibitor), the EPR-signal in the presence of reduced
DBMIB di¡ered measurably from that of the control sample,
both with respect to the gy-line and the gx-trough. This dem-
onstrated that DBMIBH2 in fact bound to the Qo-site in the
vicinity of the Rieske cluster. The results depicted in Fig. 1b
corroborated this result by showing that reduced DBMIB was
able to displace oxidised DBMIB from its binding site yielding
a decrease of the g = 1.94 signal and an increase of the g = 1.89
line. The high concentrations of cytochrome b6f complex used
for the spectra in Fig. 1 required amounts of DBMIB and
DBMIBH2 that entailed problems related to inequivalent sol-
ubilities. Titrating away the 1.94 signal by addition of
DBMIBH2 in signi¢cantly less concentrated samples allowed
us to estimate that the a⁄nity of the reduced form of the
inhibitor for the Qo-site is about 500-fold lower than that of
the oxidised form. These results furthermore indicated that
the binding sites for oxidised DBMIB and reduced DBMIB
were at least overlapping if not similar.
As evidenced by these data, fully reduced DBMIB binds to
the Qo-site and interacts with the [2Fe-2S]-cluster of the
Rieske protein. The dramatic spectral changes induced by
the oxidised form of DBMIB, however, are absent in the
presence of DBMIBH2 and the modi¢cations of the EPR
spectrum rather resemble those observed for the case of other
inhibitors such as stigmatellin or UHDBT [18].
Fig. 2 shows an experiment where the semireduced form of
DBMIB has been generated by turnover of the cytochrome
b6f complex rather than by equilibrium titrations as per-
formed by Malkin [23]. A slight excess of chemically reduced
DBMIB was added to fully oxidised (Fig. 2a vs. b) cyto-
chrome b6f complex. A small 1.89 signal (about 30% of the
total chemically reduced amplitude represented by the dotted
spectrum) was induced by this addition of DBMIBH2 (Fig.
2b; for a discussion of the nature of this signal, see below).
Subsequent addition of a 10-fold excess of oxidised DBMIB
(i.e. no further reducing equivalents were injected into the
system) resulted in the appearance of a g = 1.94 line together
with a slight increase of the g = 1.89 signal. This shows that in
spectrum 2b, a signi¢cant fraction of reduced Rieske clusters
were in an EPR-silent state. Further addition of oxidised
DBMIB increased the signal amplitude of the gy = 1.94 line
(not shown) indicating that the binding a⁄nity for the semi-
quinone form of DBMIB to the Qo-site exceeded those of
both the fully oxidised and the fully reduced forms. An exact
value for the relative binding a⁄nities, however, could not be
obtained due to the fact that the required high concentrations
of DBMIB in the sample tended to denature the complex.
Our results thus con¢rm Malkin’s hypothesis of an EPR-
silent state formed by the DBMIB semiquinone and the re-
duced Rieske cluster. Since the data shown in Fig. 1 further-
more demonstrated that the fully reduced quinol form of
DBMIB still bound to the Qo-site and a¡ected the EPR spec-
Fig. 1. EPR spectra of the Rieske [2Fe-2S]-cluster in puri¢ed cyto-
chrome b6f complex (10 WM in cytochrome f) from spinach chloro-
plasts in the presence and absence of reduced and oxidised DBMIB.
(a) The dotted spectrum was taken on the ascorbate reduced protein
in the absence of DBMIB. After addition of 100 WM DBMIBH2,
the continuous spectrum was recorded. The lower traces showing
the gx-trough are expanded 4-fold with respect to the main spectra.
The gy-lines are furthermore depicted on a wider magnetic ¢eld
scale (expanded by a factor of 2.5) in order to visualise the spectral
changes induced by DBMIBH2. (b) When oxidised DBMIB (50 WM)
rather than the reduced form was added to the ascorbate-reduced
enzyme, the dotted spectrum was obtained. Subsequent addition of
15 mM DBMIBH2 resulted in conversion into the continuous spec-
trum. Instrument settings: temperature, 20 K; microwave frequency,
9.44 GHz; modulation amplitude, 1.6 mT; microwave power,
6.3 mW.
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trum of the Rieske cluster, all three reduction states of
DBMIB therefore strongly interact with the [2Fe-2S]-centre
of the Rieske protein. In the mitochondrial cytochrome bc1
complex, the Rieske protein was shown to pivot between a
‘proximal’ state close to the Qo-site and a ‘distal’ state close to
cytochrome c1 [2,3]. The observed strong interactions of all
redox states of DBMIB with the [2Fe-2S]-cluster implied that
in the presence of the inhibitor the bf Rieske protein had to be
in a conformation equivalent to the proximal position. An
examination of the orientations of the Rieske cluster’s mag-
netic axes in two-dimensionally ordered samples (Fig. 3) in-
deed provided evidence for substantially di¡ering conforma-
tional equilibria in the presence and absence of the inhibitor.
Fig. 3b shows the orientation-dependences of the Rieske clus-
ter’s gz-, gy- and gx-signals (see spectra in Fig. 3a) with respect
to the membrane. The polar plots of gz and gy were charac-
terised by a poor anisotropy as already reported [18,29,30].
We have previously shown that the gy-signal actually con-
sisted of two or more components di¡ering in EPR relaxation
properties [18]. In our previous work, we have discussed the
possibility that the observed e¡ects may re£ect di¡ering
orientations of the Rieske cluster but strongly favoured a
purely physical interpretation of the observed phenomena
[18]. The recent demonstration of a domain movement of
the Rieske protein in mitochondrial cytochrome bc1 complex
[2], however, showed that the interpretation invoking confor-
mational heterogeneity of the Rieske protein, discarded in
[18], was in fact correct. A detailed reinterpretation of the
respective data in the light of the Rieske protein’s conforma-
tional £exibility will be presented elsewhere.
When the sample used for the experiments of Fig. 3a, b was
sprayed with a solution containing DBMIB followed by re-
drying under a stream of argon, the spectra shown in Fig. 3a
were converted into those depicted in Fig. 3c, featuring signals
characteristic of the Rieske protein in the presence of
DBMIB. In contrast to the uninhibited centre, the principal
g-directions were well-ordered parallel (gz and gy) and perpen-
dicular (gx) to the membrane in the presence of DBMIB. It is
of note that the signal at about g = 1.89, which arises from gy
in the uninhibited Rieske centre (Fig. 3a), mainly re£ected the
gx-direction of the inhibitor-induced spectrum (Fig. 3c). This
is evident from the facts that (a) gz and gx of the uninhibited
centre have dramatically diminished upon addition of DBMIB
whereas still more than half of the g = 1.89 signal parallel to
the membrane can be observed (Fig. 3c) and that (b) the two
g-tensor orientations gz = 2.01 and gy = 1.94 parallel to the
membrane require a third orthonormal gx-direction for which
no other candidate than the g = 1.89 signal is detectable in the
spectrum. The attribution of the g = 1.89 line as the gx-trough
of the rhombic DBMIB-induced spectrum of the Rieske clus-
ter is in line with the fact that we detected this signal even
under conditions where high concentrations of DBMIB were
present (e.g. see Fig. 1b). Respective observations have been
reported previously for thylakoid membranes [29,30] and oth-
er cytochrome bc complexes [4]. By contrast, Malkin has re-
ported that the g = 1.89 signal can be fully interconverted into
the g = 1.94 signal using saturating concentrations of DBMIB
[23,24]. At present, we have no explanation for these di¡er-
ences.
As stated above, the Rieske protein is in the proximal posi-
tion in the presence of DBMIB. In this state, the Fe-Fe-axis of
the cluster of the X-ray structure [2] is seen to be perpendic-
ular to the plane of the membrane. The fact that the same
orientation was observed for the gx-axis (Fig. 3d) demon-
strates that gx is collinear with the Fe-Fe-axis, in line with
independent evidence obtained on a purple bacterial complex
[5].
Addition of DBMIB therefore displaces the equilibrium dis-
tribution of the Rieske protein from a rather heterogeneous
population (Fig. 3b) towards a new equilibrium strongly fa-
vouring the proximal position (Fig. 3d). This demonstrates the
presence of a conformational £exibility of the Rieske protein
in the plastidic cytochrome b6f complex analogous to that
seen in the X-ray structures of the mitochondrial cytochrome
bc1 complex [2,3]. Independent evidence for this conforma-
tional £exibility of the plastidic Rieske protein has also been
obtained by the experimental procedure described in [5] (Bay-
mann, Brugna, Wollman and Nitschke, unpublished).
As can be seen from Fig. 3c, the gz- and gx-signals of the
uninhibited Rieske centre, although substantially diminished,
were still visible, even after repeated treatment with DBMIB
(not shown). These residual signals from the uninhibited
centre can be due to (a) incomplete penetration of the inhib-
itor solution into the oriented multilayer, (b) presence of
Rieske proteins detached from the complex or (c) presence
of a population of complexes where the Rieske protein is in
the distal state, i.e. too far away from the Qo-site to interact
with the inhibitor. While the gx-signal at g = 1.78 was too
small to be evaluated and while the gy-signal at 1.89 was
strongly overlapped by the gx-trough of the inhibitor-a¡ected
spectrum, the intensity of the gz-peak at g = 2.03 could still be
determined with su⁄cient precision yielding the orientation-
dependence depicted in Fig. 3d (open triangles). The signal
was found to still be orientationally anisotropic arguing
against the rationalisation invoking detached Rieske protein.
The angular dependence, however, di¡ered from that ob-
served in the uninhibited state and showed a maximum at
Fig. 2. 2 WM of DBMIBH2 were added (b) to puri¢ed cytochrome
b6f complex (1.5 WM in cytochrome f) in which the Rieske protein
was poised in the oxidised state (a), followed by additional treat-
ment with 15 WM oxidised DBMIB (c). The dotted curve in (b) rep-
resents the full signal of the Rieske cluster obtained by reduction
with 5 mM ascorbate. Instrument settings, see Fig. 1.
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about 60‡ to the membrane in addition to that observed at 0‡.
We would therefore hesitate to exclude the possibility that,
even in the presence of DBMIB, a fraction of Rieske clusters
were in a conformation di¡ering from the proximal state and
thus insensitive to spectral alterations induced by DBMIB.
This could also provide a rationale for the g = 1.89 signal
observed in Fig. 2b. A more detailed investigation of these
centres is presently underway in our laboratories.
In the EPR redox titration at pH 8.0, Malkin [23] observed
the electrochemical transition of the Rieske cluster in the pres-
ence of oxidised DBMIB (i.e. between states 1 and 2, see
Scheme 1) at Em = 180 mV, i.e. about 140 mV lower than
what was found in the uninhibited enzyme. DBMIB-binding
was therefore considered to alter the redox potential of the
Rieske protein as also observed for other inhibitors, such as
stigmatellin [31,32] or UHDBT [33]. In this EPR titration, the
DBMIB-induced g = 1.94 signal of the Rieske cluster was seen
to disappear at lower potentials with an apparent Em-value of
+20 mV. As mentioned above, the loss of the Rieske spectrum
must be attributed to antiferromagnetic interaction between
the DBMIB semiquinone and the Rieske cluster (state 3).
We have performed EPR redox titrations similar to that
reported by Malkin [23], however, covering a range of pH-
values from 5.6 to 8.0. Unlike the remaining data reported in
this work, these pH-dependent redox titrations were per-
formed on spinach thylakoids since puri¢ed cytochrome b6f
complex tended to denature in the presence of DBMIB during
the several hours of an EPR redox titration. The obtained
data (Fig. 4) demonstrated that, rather than inducing a strong
absolute shift of about 140 mV in the Rieske cluster’s Em-
value (as reported in [23]), the Em vs. pH curve was shifted
by 1.5 pH units towards more acidic values as compared to
that of the uninhibited enzyme [34] together with a relatively
small e¡ect of about 40^50 mV on the Em-value in the pH-
independent region. The Em-value for the formation of the
EPR-silent Rieske/semireduced DBMIB state at lower poten-
tials (open triangles) was also pH-dependent (about 360 mV/
pH, dotted line), but did not show a pK-value within the
examined pH-range. This implies that the single electron re-
duction of DBMIB involves a protonation step and we have
therefore denoted the semiquinone species as ‘DBMIBHW’ in
Scheme 1 (state 3) in contrast to Malkin’s original proposal
[23]. Zhang et al. [35] have recently reported a pK-value for
Scheme 1.
Fig. 3. Orientation of the Rieske cluster’s g-tensor in the presence (c, d) and absence (a, b) of DBMIB. EPR spectra of the Rieske centre were
recorded on oriented samples in the absence of DBMIB (a). The samples were subsequently treated with DBMIB until saturation of the
g = 1.94 signal had been achieved (c). Continuous and dotted spectra in (a) and (c) were taken with the magnetic ¢eld parallel and perpendicu-
lar to the plane of the mylar sheets, respectively. (b) and (d) represent polar plots of the signals observed at g = 2.03 (open triangles), 2.01
(¢lled triangles), 1.94 (¢lled squares), 1.89 (open squares in (b) and ¢lled diamonds in (d)) and 1.78 (open diamonds). Open and ¢lled symbols
denote spectral features arising from the uninhibited and DBMIB-treated samples, respectively. Instrument settings, see Fig. 1.
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the b6f Rieske protein (obtained by an optical titration at
room temperature on the isolated soluble fragment) that de-
viated from that determined by EPR on thylakoids at cryo-
genic temperatures [34] and have concluded that the discrep-
ancy is due to a temperature-dependence of this pK-value.
This appears highly unlikely to us since in the other cyto-
chrome bc complexes studied so far, no major di¡erence
was observed between the optical (RT) and EPR measure-
ments (e.g. [10], for a more detailed discussion of this prob-
lem, see [6]).
The results of the pH-dependent redox titration show that
the principal e¡ect of DBMIB on the electrochemical proper-
ties of the Rieske cluster lies in a destabilisation of the redox-
linked proton. This proton is generally believed to correspond
to the NO-proton of one of the cluster-ligating histidine resi-
dues [36^38]. The hypothetical structural model of DBMIB in
the Qo-site of cytochrome b6f complex depicted in Fig. 5 (in-
spired by the X-ray structure of the mitochondrial cytochrome
bc1 complex) visualises possible molecular bases for the ob-
served e¡ects. Either the bromide substituent (due to its neg-
ative partial charge) or the oxygen atom adjacent to the
Rieske cluster or both may form a hydrogen bridge with the
NO-proton of one of the histidine ligands. Such a hydrogen
bond is likely to stabilise the Rieske protein in the proximal
conformation. On the other side, these interactions must be
expected to destabilise the bond strength of the NO-proton, i.e.
to lower its pK-value.
The fact that the described phenomena can be observed in
the presence of DBMIB suggests the possibility that the re-
duction state (oxidised, reduced or semireduced) of the native
substrate quinone may also in£uence the redox potential of
the Rieske cluster and/or the pK-value of the redox-linked
proton. DBMIBH2 in fact resembles the physiological sub-
strate plastoquinol in that it is a good electron donor to the
Rieske protein. The inhibitory action mainly arises from the
fact that the semiquinone state of DBMIB formed after elec-
tron donation to the Rieske protein is not su⁄ciently reducing
to allow electron transfer towards heme bL.
In a recent study addressing the question of a possible ac-
cumulation of a Qo-site semiquinone during turnover of the
cytochrome bc1 complex [9], neither a signal from semiqui-
none nor from reduced Rieske cluster could be observed
under conditions of oxidant-induced reduction. In this work,
the authors mention the possibility that an antiferromagneti-
cally coupled pair formed by semiquinone and the reduced
Rieske cluster might explain the experimental results. The
above described EPR-silent pair DBMIB:[2Fe-2S]red substan-
tiates this possibility and is likely to provide a promising
model system for the study of such a state during normal
turnover of the complex.
It is of note that the detailed geometry of DBMIB and in
particular the position of the bromide atoms with respect to
the Rieske cluster is only one of a set of di¡erent possibilities.
We expect that an examination of the range of DBMIB-de-
rivatives described previously [21] with respect to the phenom-
ena reported in this work will provide a more detailed picture
of the interaction between quinones and quinone analogs in
the Qo-site and the Rieske cluster.
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